Доступ предоставлен для: Guest
Портал Begell Электронная Бибилиотека e-Книги Журналы Справочники и Сборники статей Коллекции
International Journal of Medicinal Mushrooms
Импакт фактор: 1.211 5-летний Импакт фактор: 1.394 SJR: 0.433 SNIP: 0.661 CiteScore™: 1.38

ISSN Печать: 1521-9437
ISSN Онлайн: 1940-4344

Том 21, 2019 Том 20, 2018 Том 19, 2017 Том 18, 2016 Том 17, 2015 Том 16, 2014 Том 15, 2013 Том 14, 2012 Том 13, 2011 Том 12, 2010 Том 11, 2009 Том 10, 2008 Том 9, 2007 Том 8, 2006 Том 7, 2005 Том 6, 2004 Том 5, 2003 Том 4, 2002 Том 3, 2001 Том 2, 2000 Том 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2018028771
pages 1065-1074

Studies of the Antimicrobial Activity of Mushrooms (Agaricales) from South America (Review)

Marina Giombelli Rosenberger
Graduate Program in Botany, Federal University of Parana, Curitiba, PR, Brazil
Roberta Paulert
Department of Agronomic Sciences, Federal University of Parana, Palotina, PR, Brazil
Vagner G. Cortez
Graduate Program in Botany, Federal University of Parana, Curitiba, PR, Brazil

Краткое описание

South America harbors much of the world's biodiversity, representing a potential reservoir of species with diverse possibilities for use. From this perspective, mushroom species are included because they naturally produce a wide variety of substances, especially ones with antimicrobial activity. In this article we present a review of the literature on the antimicrobial activity of mushrooms collected in South America, emphasizing the bacteria and fungi these mushrooms inhibit, the main methodologies researchers use for antimicrobial tests, and some directions for future research. This review demonstrates that the agar diffusion test was the most prevalent method in studies of South American mushrooms. Most studies dealt with specimens collected in Chile (16 species), Brazil (10 species), and Uruguay (2 species), and 27 of those species presented antimicrobial activity. Furthermore, most research developed with Basidiomycetes in South America aimed only to screen antimicrobial agents, whereas few studies explored the antimicrobial potential of purified secondary metabolites. Thus it is very important to conduct research in order to screen for and isolate antimicrobial substances, which researchers can then use to develop new antimicrobial drugs.

Articles with similar content:

Biotechnological Potential of Mushrooms: Drugs and Dye Production
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Girish Tidke, Mahendra K. Rai
Medicinal Properties of the Genus Clitocybe and of Lectins from the Clouded Funnel Cap Mushroom, C. nebularis (Agaricomycetes): A Review
International Journal of Medicinal Mushrooms, Vol.18, 2016, issue 11
Jure Pohleven, Janko Kos, Jerica Sabotic
A Survey of Southeast North American Wild Growing Macromycetes (Higher Basidiomycetes and Ascomycetes) Sporophores for Biological Activity
International Journal of Medicinal Mushrooms, Vol.5, 2003, issue 2
Samir A. Ross, Christine J. G. Duncan, William Cibula
Effects of Culture Conditions on Antimicrobial Activity of Ganoderma resinaceum (Agaricomycetes) Extracts
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 8
Alvaro Vázquez, María Pía Cerdeiras, Stephanie Barneche, Gabriela Jorcin, Silvana Alborés
Growth-Inhibitory and Immunomodulatory Activities of Wild Mushrooms from North-Central British Columbia (Canada)
International Journal of Medicinal Mushrooms, Vol.19, 2017, issue 6
Chow H. Lee, Vicky Myhre, Aaron Smith, Sumreen Javed, Linda E. Tackaberry, Ankush Barad, Keith N. Egger, Kerry Reimer, Hugues B. Massicotte, Wai Ming Li, Geoffrey W. Payne